Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

NCT05728632 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Lymphoma, Large B-Cell, Diffuse
Cardiotoxicity
Left Ventricular Dysfunction
Chemotherapy Effect

Interventions

DRUG: Nebivolol
DRUG: Placebo

Sponsor

Giulio Stefanini

Collaborators

[object Object]